Clinical Trial

HPV Specific Immune Lymphocytes (HPV-CTLs) in the Treatment of HPV

Name: HPV Specific Immune Lymphocytes (HPV-CTLs) in the Treatment of HPV — clinical trial record (NCT03351855)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Recruiting Phase 1/2

View on ClinicalTrials.gov →

Summary

The purpose of this clinical trial is to evaluate the safety and efficacy of IV-infused autologous or allogenic HPV-CTLs.

Protocol Amendment History 2 amendments

This ClinicalTrials.gov record has been amended 2 times since 2017-11-20; most recent amendment 2026-06-18.

Trial Details

NCT Number	NCT03351855
Lead Sponsor	Shenzhen Geno-Immune Medical Institute
Conditions	Human Papilloma Virus
Enrollment	100 participants
Start Date	2026-06-01
Primary Completion	2029-12-31 (estimated)
Study Completion	2030-12-31 (estimated)
Updated on ClinicalTrials.gov	2026-06-23